(Q47940160)
Statements
1 reference
Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma. (English)
1 reference
Yuji Oba
1 reference
Gary A Salzman
1 reference
1 August 2004
1 reference
114
1 reference
2
1 reference
265-269
1 reference
Identifiers
1 reference
1 reference